See Patient information leaflet here
£39.99 – £104.99
Incruse Ellipta (umeclidinium) is an anticholinergic that works by relaxing muscles in the airways to improve breathing. Incruse Ellipta is used to prevent airflow obstruction and reduce flare-ups in adults with COPD (chronic obstructive pulmonary disease), including bronchitis and emphysema. Incruse Ellipta is for use only in people with COPD and should not be used to treat asthma.The usual dose is 1 inhalation per day. Use the medicine at the same time each day, and not more than once in a 24-hour period Throw the inhaler away 6 weeks after opening, or when the dose indicator shows a zero (whichever comes first).
These product images are for illustrative purposes only.